Author:
Billington Emma O.,Grey Andrew,Bolland Mark J.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference51 articles.
1. Yki-Jarvinen H (2004) Thiazolidinediones. N Engl J Med 351:1106–1118
2. Dream Trial Investigator, Gerstein HC, Yusuf S et al (2006) Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 368:1096–1105
3. Kahn SE, Haffner SM, Heise MA et al (2006) Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 355:2427–2443
4. Loke YK, Singh S, Furberg CD (2009) Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. CMAJ 180:32–39
5. Bazelier MT, de Vries F, Vestergaard P et al (2013) Risk of fracture with thiazolidinediones: an individual patient data meta-analysis. Front Endocrinol 4:1–9
Cited by
102 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献